Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Robust Antibody and T Cell Responses to SARS-CoV-2 in Patients with Antibody Deficiency.

Journal of clinical immunology - 1 Aug 2021

Kinoshita Hannah, Durkee-Shock Jessica, Jensen-Wachspress Mariah, Kankate Vaishnavi V, Lang Haili, Lazarski Christopher A, Keswani Anjeni, Webber Kathleen C, Montgomery-Recht Kimberly, Walkiewicz Magdalena, Notarangelo Luigi D, Burbelo Peter D, Fuss Ivan, Cohen Jeffrey I, Bollard Catherine M, Keller Michael D

Abstract excerpt

Immunocompromised patients, including those with inborn errors of immunity (IEI), may be at increased risk for severe or prolonged infections with SARS-CoV-2 (Zhu et al. N Engl J Med. 382:727-33, 2020; Guan et al. 2020; Minotti et al. J Infect. 81:e61-6, 2020). While antibody and T cell responses to SARS-CoV-2 structural proteins are well described in healthy convalescent donors, adaptive humoral and cellular...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Viral
Share to Carrier State

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Common Variable Immunodeficiency

Share to COVID-19

Share to Immunity, Humoral

Share to Lymphocyte Activation

Share to SARS-CoV-2

Share to Transmembrane Activator and CAML Interactor Protein

Source

Open in PubMed Open full text

Identifiers

PMID: 33983545
DOI: 10.1007/s10875-021-01046-y
PMCID: PMC8117127

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Robust Antibody and T Cell Responses to SARS-CoV-2 in Patients with Antibody Deficiency.PMID 33983545Read ↗

SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings From The COV-AD StudySemantic proximity Read ↗

Typically asymptomatic but with robust antibody formation: Children’s unique humoral immune response to SARS-CoV-2Semantic proximity Read ↗

Identification of IgG antibody response to SARS-CoV-2 spike protein and its receptor binding domain does not predict rapid recovery from COVID-19Semantic proximity Read ↗

An Overview of the Immune Response to COVID-19 Vaccination and Strategies to Boost SARS-CoV-2 Immunity in People with Inborn Errors of ImmunitySemantic proximity Read ↗

SARS-CoV-2 Vaccine Induced Atypical Immune Responses in Antibody Defects: everybody does their bestSemantic proximity Read ↗

Preserved T-Cell Immunity Despite Impaired Humoral Responses following SARS-CoV-2 Infection and Vaccination in Children with Profound B-cell LymphopeniaSemantic proximity Read ↗

Evaluation of Humoral and Cellular Immune Responses to the SARS-CoV-2 Vaccine in Patients With Common Variable Immunodeficiency Phenotype and Patient Receiving B-Cell Depletion Therapy.Semantic proximity Read ↗

Antibody response to SARS-CoV-2 infection in humans: a systematic reviewSemantic proximity Read ↗

A systematic review of antibody mediated immunity to coronaviruses: antibody kinetics, correlates of protection, and association of antibody responses with severity of diseaseSemantic proximity Read ↗

Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production.Semantic proximity Read ↗

Infants and young children generate more durable antibody responses to SARS-CoV-2 infection than adultsSemantic proximity Read ↗

Lasting antibody and T cell responses to SARS-CoV-2 in COVID-19 patients three months after infection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.